Skip to main content
NCBI home page
Journal of the National Medical Association logoLink to Journal of the National Medical Association
. 2003 May;95(5):352–362.

Antimicrobial susceptibility patterns of urinary pathogens in Trinidad, 1996-1999.

F A Orrett 1
PMCID: PMC2594504  PMID: 12793792

Abstract

The prevalence of antimicrobial resistance among urinary pathogens has been increasing worldwide. Laboratory diagnosed urinary tract infections were retrospectively evaluated for the years 1996 through 1999, to document the common pathogens and their changing antimicrobial profiles. From 14,853 hospital specimens, an isolation rate of 6.1% was found; and from 5330 community specimens, the isolation rate was 27.9%. E. coli was the predominant cause of urinary tract infections in both hospital and community practices. The rate of isolation of the other pathogens was relatively stable except for citrobacter species, which increased from 1.3% in 1996 to 20.1% in 1999 (p < 0.001) among community isolates. Significant changes in the susceptibility patterns of uropathogens also were observed. E. coli strains from hospitals were significantly more resistant to cefuroxime than community strains (p < 0.001), while resistance to ampicillin and nalidixic acid was high in both practices. No substantial changes in susceptibility to gentamicin and tetracycline were noticed during the four-year period compared to the 99% resistance to tetracycline in 1995. In relation to nitrofurantoin, no significant changes were noted in both practices where resistant rates remained low, but susceptibility to augmentin showed much improvement among all isolates, including E. coli. Urinary isolates were more commonly recovered from the paediatric age group (1-10 years) and those older than 50 years of age, and males were the predominant gender in both age groups. The study showed that the antibiotics useful in the treatment of UTI in decreasing order of effectiveness in community practice were gentamicin, norfloxacin, nitrofurantoin and cefuroxime. For nosocomial UTI, the drugs most effective include norfloxacin, nitrofurantoin, gentamicin, co-trimoxazole and amoxicillin-clavulanic acid.

Full text

PDF
352

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ako-Nai A. K., Kassim O. O., Adeniran M. O., Taiwo O. A study of urinary tract infections at Ile-Ife, Nigeria. East Afr Med J. 1993 Jan;70(1):10–14. [PubMed] [Google Scholar]
  2. Altmann G., Sechter I., Cahan D., Gerichter C. B. Citrobacter diversus isolated from clinical material. J Clin Microbiol. 1976 Apr;3(4):390–392. doi: 10.1128/jcm.3.4.390-392.1976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aseffa A., Yohannes G. Antibiotic sensitivity pattern of prevalent bacterial pathogens in Gondar, Ethiopia. East Afr Med J. 1996 Jan;73(1):67–71. [PubMed] [Google Scholar]
  4. Bauer A. W., Kirby W. M., Sherris J. C., Turck M. Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966 Apr;45(4):493–496. [PubMed] [Google Scholar]
  5. Doran T. I. The role of Citrobacter in clinical disease of children: review. Clin Infect Dis. 1999 Feb;28(2):384–394. doi: 10.1086/515106. [DOI] [PubMed] [Google Scholar]
  6. Dornbusch K. Resistance to beta-lactam antibiotics and ciprofloxacin in gram-negative bacilli and staphylococci isolated from blood: a European collaborative study. European Study Group on Antibiotic Resistance. J Antimicrob Chemother. 1990 Aug;26(2):269–278. doi: 10.1093/jac/26.2.269. [DOI] [PubMed] [Google Scholar]
  7. Drelichman V., Band J. D. Bacteremias due to Citrobacter diversus and Citrobacter freundii. Incidence, risk factors, and clinical outcome. Arch Intern Med. 1985 Oct;145(10):1808–1810. [PubMed] [Google Scholar]
  8. Ferry S., Burman L. G., Mattsson B. Urinary tract infection in primary health care in northern Sweden. I. Epidemiology. Scand J Prim Health Care. 1987 May;5(2):123–128. doi: 10.3109/02813438709013988. [DOI] [PubMed] [Google Scholar]
  9. Fields B. N., Uwaydah M. M., Kunz L. J., Swartz M. N. The so-called "Paracolon" bacteria. A bacteriologic and clinical reappraisal. Am J Med. 1967 Jan;42(1):89–106. doi: 10.1016/0002-9343(67)90008-3. [DOI] [PubMed] [Google Scholar]
  10. Gedebou M. Urinary tract infections: aetiologic patterns and resistance. Ethiop Med J. 1983 Jan;21(1):3–13. [PubMed] [Google Scholar]
  11. Grüneberg R. N. Changes in urinary pathogens and their antibiotic sensitivities, 1971-1992. J Antimicrob Chemother. 1994 May;33 (Suppl A):1–8. doi: 10.1093/jac/33.suppl_a.1. [DOI] [PubMed] [Google Scholar]
  12. Hannan M., Cormican M., Flynn J. A comparison of antimicrobial sensitivities of urinary pathogens for the years 1980 and 1990. Ir J Med Sci. 1993 Dec;162(12):499–501. doi: 10.1007/BF03022582. [DOI] [PubMed] [Google Scholar]
  13. Hodges G. R., Degener C. E., Barnes W. G. Clinical significance of citrobacter isolates. Am J Clin Pathol. 1978 Jul;70(1):37–40. doi: 10.1093/ajcp/70.1.37. [DOI] [PubMed] [Google Scholar]
  14. Hooton T. M., Stam W. E. Management of acute uncomplicated urinary tract infection in adults. Med Clin North Am. 1991 Mar;75(2):339–357. doi: 10.1016/s0025-7125(16)30458-8. [DOI] [PubMed] [Google Scholar]
  15. Lipsky B. A., Hook E. W., 3rd, Smith A. A., Plorde J. J. Citrobacter infections in humans: experience at the Seattle Veterans Administration Medical Center and a review of the literature. Rev Infect Dis. 1980 Sep-Oct;2(5):746–760. doi: 10.1093/clinids/2.5.746. [DOI] [PubMed] [Google Scholar]
  16. Maartens G., Oliver S. P. Antibiotic resistance in community-acquired urinary tract infections. S Afr Med J. 1994 Sep;84(9):600–602. [PubMed] [Google Scholar]
  17. Madrazo A., Geiger J., Lauter C. B. Citrobacter diversus at Grace Hospital, Detroit, Michigan. Am J Med Sci. 1975 Nov-Dec;270(3):497–501. doi: 10.1097/00000441-197511000-00011. [DOI] [PubMed] [Google Scholar]
  18. Mathewson J. J., Murray B. E. Plasmid-mediated resistance to trimethoprim-sulfamethoxazole in Salmonella krefeld strains isolated in the United States. Antimicrob Agents Chemother. 1983 Mar;23(3):495–496. doi: 10.1128/aac.23.3.495. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. McAllister T. A., Alexander J. G., Dulake C., Percival A., Boyce J. M., Wormald P. J. Multicentric study of sensitivities of urinary tract pathogens. Postgrad Med J. 1971 Sep;47(Suppl):7–14. [PubMed] [Google Scholar]
  20. Orrett F. A., Shurland S. M. The changing patterns of antimicrobial susceptibility of urinary pathogens in Trinidad. Singapore Med J. 1998 Jun;39(6):256–259. [PubMed] [Google Scholar]
  21. Schaberg D. R., Culver D. H., Gaynes R. P. Major trends in the microbial etiology of nosocomial infection. Am J Med. 1991 Sep 16;91(3B):72S–75S. doi: 10.1016/0002-9343(91)90346-y. [DOI] [PubMed] [Google Scholar]
  22. Scully P. G., O'Shea B., Flanagan K. P., Falkiner F. R. Urinary tract infection in general practice: direct antibiotic sensitivity testing as a potential diagnostic method. Ir J Med Sci. 1990 Apr;159(4):98–100. doi: 10.1007/BF02937439. [DOI] [PubMed] [Google Scholar]
  23. Stone A. M., Tucci V. J., Isenberg H. D., Wise L. Wound infection: a prospective study of 7519 operations. Am Surg. 1976 Nov;42(11):849–852. [PubMed] [Google Scholar]
  24. Thomson K. S., Sanders W. E., Sanders C. C. USA resistance patterns among UTI pathogens. J Antimicrob Chemother. 1994 May;33 (Suppl A):9–15. doi: 10.1093/jac/33.suppl_a.9. [DOI] [PubMed] [Google Scholar]
  25. Weinstein M. P., Reller L. B., Murphy J. R. Clinical importance of polymicrobial bacteremia. Diagn Microbiol Infect Dis. 1986 Sep;5(3):185–196. doi: 10.1016/0732-8893(86)90001-5. [DOI] [PubMed] [Google Scholar]

Articles from Journal of the National Medical Association are provided here courtesy of National Medical Association

RESOURCES